Patents by Inventor Jeffrey A. Stuart

Jeffrey A. Stuart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150225783
    Abstract: A system and method of identifying a print includes an image-capturing and lighting optical system configured to maximize specular reflection of light reflected from a print and to minimize diffused reflection of light reflected from a background surface of the print via adjustment of at least one of a frequency and a reflection angle of the light emitted upon a sample of the print. The system and method also include an IC having one or more FETs with a nanostructure configured to detect a plurality of analytes from the print. The system and method also include a nucleic acid analyzer configured to process the print and to determine a DNA content of the print. There is no contact made with the print, while being subjected to processing by the image-capturing and lighting optical system and the IC.
    Type: Application
    Filed: February 10, 2015
    Publication date: August 13, 2015
    Applicant: LOCKHEED MARTIN CORPORATION
    Inventors: John Cleon Mears, Jeffrey A. Stuart
  • Patent number: 8236243
    Abstract: A nano-structured device for detecting biological analytes, chemical, analytes, cancer and other physiological conditions, includes a carrier substrate, a transducer film disposed over a surface of the carrier substrate, and a dendrimer structure tethered to the transducer film. The transducer film generates a first signal in response to a mechanical stress applied thereto. The first signal indicates the detection of the biological analyte, chemical analyte, cancer or other physiological condition. The dendrimer structure includes a plurality of receptors for binding the biological analyte, the chemical analyte, or one or more biomarkers indicative of cancer or other physiological conditions to the dendrimer structure.
    Type: Grant
    Filed: January 2, 2009
    Date of Patent: August 7, 2012
    Assignee: Lockheed Martin Corporation
    Inventors: Patricia D. Palena, Richard R. Barto, Jr., Tammie L. Borders, Jeffrey A. Stuart
  • Patent number: 8163539
    Abstract: A bacteriorhodopsin based chemical sensing architecture based upon the collective response of bacteriorhodopsin and a number of its mutants; the wild type protein and a selection of genetically-engineered variants was able to respond differentially to a selection of amines. The observable response to the presence of a target chemical was manifested through a modulation of bacteriorhodopsin's photokinetic properties, which are monitored through pump-probe techniques using a custom prototype flash photolysis system. Differential responsivity exists at two levels; (1) bacteriorhodopsin proteins (wild-type and genetically-engineered variants) respond differentially upon exposure of a target chemical, and (2) the response pattern exhibited by the proteins differs from chemical to chemical. This dichotomy forms the basis for a BR-mediated chemical sensing technology that is highly sensitive and selective and may therefore discriminate between different chemicals.
    Type: Grant
    Filed: July 20, 2010
    Date of Patent: April 24, 2012
    Assignee: Syracuse University
    Inventors: Jeffrey A. Stuart, Duane L. Marcy, Robert R. Birge
  • Publication number: 20110171747
    Abstract: A bacteriorhodopsin based chemical sensing architecture based upon the collective response of bacteriorhodopsin and a number of its mutants; the wild type protein and a selection of genetically-engineered variants was able to respond differentially to a selection of amines. The observable response to the presence of a target chemical was manifested through a modulation of bacteriorhodopsin's photokinetic properties, which are monitored through pump-probe techniques using a custom prototype flash photolysis system. Differential responsivity exists at two levels; (1) bacteriorhodopsin proteins (wild-type and genetically-engineered variants) respond differentially upon exposure of a target chemical, and (2) the response pattern exhibited by the proteins differs from chemical to chemical. This dichotomy forms the basis for a BR-mediated chemical sensing technology that is highly sensitive and selective and may therefore discriminate between different chemicals.
    Type: Application
    Filed: July 20, 2010
    Publication date: July 14, 2011
    Applicant: SYRACUSE UNIVERSITY
    Inventors: Jeffrey A. Stuart, Duane L. Marcy, Robert R. Birge
  • Patent number: 7790442
    Abstract: A bacteriorhodopsin based chemical sensing architecture based upon the collective response of bacteriorhodopsin and a number of its mutants; the wild type protein and a selection of genetically-engineered variants was able to respond differentially to a selection of amines. The observable response to the presence of a target chemical was manifested through a modulation of bacteriorhodopsin's photokinetic properties, which are monitored through pump-probe techniques using a custom prototype flash photolysis system. Differential responsivity exists at two levels; (1) bacteriorhodopsin proteins (wild-type and genetically-engineered variants) respond differentially upon exposure of a target chemical, and (2) the response pattern exhibited by the proteins differs from chemical to chemical. This dichotomy forms the basis for a BR-mediated chemical sensing technology that is highly sensitive and selective and may therefore discriminate between different chemicals.
    Type: Grant
    Filed: July 19, 2007
    Date of Patent: September 7, 2010
    Assignee: Syracuse University
    Inventors: Jeffrey A. Stuart, Duane Marcy, Robert R. Birge
  • Patent number: 7700010
    Abstract: A binary optical compound formed from a preparation of proteorhodopsin, is provided. The preparation is prepared by dissolving proteorhodopsin in distilled water, where the pH is adjusted to be above 11 either by using sodium hydroxide or an appropriate buffer. The preparation is then illuminated with either white light sources, lasers, or irradiation provided from light-emitting diodes. The necessary duration is intensity dependent, varying from a few seconds to a few minutes, depending upon the source and actinic wavelength. The resulting compound has a long lifespan and may be efficiently transitioned between states.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: April 20, 2010
    Assignee: Syracuse University
    Inventor: Jeffrey A. Stuart
  • Publication number: 20090311799
    Abstract: Nucleic acid materials for FRET-based luminescence and methods of making and using the nucleic acid materials are provided. The nucleic acid materials provide an innovative and synergistic combination of three disparate elements: a nucleic acid material, the processing technique for forming a nucleic acid material into films, fibers, nanofibers, or non-woven meshes, and nonradiative energy transfer. This combination can be formed into electrospun fibers, nanofibers, and non-woven meshes of a nucleic acid material-cationic lipid complex with encapsulated chromophores capable of nonradiative energy transfer such as efficient Förster Resonance Energy Transfer (FRET).
    Type: Application
    Filed: June 15, 2009
    Publication date: December 17, 2009
    Inventors: Gregory A. Sotzing, Jeffrey A. Stuart, Yogesh J. Ner
  • Publication number: 20090220382
    Abstract: A nano-structured device for detecting biological analytes, chemical, analytes, cancer and other physiological conditions, includes a carrier substrate, a transducer film disposed over a surface of the carrier substrate, and a dendrimer structure tethered to the transducer film. The transducer film generates a first signal in response to a mechanical stress applied thereto. The first signal indicates the detection of the biological analyte, chemical analyte, cancer or other physiological condition. The dendrimer structure includes a plurality of receptors for binding the biological analyte, the chemical analyte, or one or more biomarkers indicative of cancer or other physiological conditions to the dendrimer structure.
    Type: Application
    Filed: January 2, 2009
    Publication date: September 3, 2009
    Applicant: LOCKHEED MARTIN CORPORATION
    Inventors: Patricia D. Palena, Richard R. Barto, JR., Tammie L. Borders, Jeffrey A. Stuart